Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-beta peptide(1-40) in mouse: involvement of an LRP-1-independent pathway - PubMed

Affiliations

• PMID: 20367755
• DOI: 10.1111/j.1471-4159.2010.06708.x

Free article

Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-beta peptide(1-40) in mouse: involvement of an LRP-1-independent pathway

Shingo Ito et al. J Neurochem. 2010 Jun.

Free article

Abstract

The contribution of low-density lipoprotein receptor-related protein-1 (LRP-1) to the brain-to-blood amyloid-beta peptide (A beta) efflux transport across the blood-brain barrier (BBB) remains controversial. The purpose of the present study was to clarify whether or not LRP-1 plays a role in efflux transport of A beta at the BBB. After microinjection of [(125)I]activated alpha2-macroglobulin (alpha 2M), a typical LRP-1 ligand, into mouse secondary somatosensory cortex region under ketamine-xylazine anesthesia, residual radioactivity was not significantly decreased up to 90 min, whereas after microinjection of [(125)I]human A beta(1-40) [hA beta(1-40)], the residual radioactivity decreased time-dependently. Co-administration of receptor-associated protein, an inhibitor of LRP-1, did not influence [(125)I]hA beta(1-40) elimination from mouse brain, suggesting that members of the LDL receptor gene family, including LRP-1, do not contribute to hA beta(1-40) elimination from mouse brain across the BBB. There was no significant difference between the uptakes of [(125)I]activated alpha 2M and [(14)C]inulin by mouse brain slices, suggesting that activated alpha 2M was not significantly bound to and/or taken up by parenchymal cells. In conclusion, our results show that LRP-1 does not play a significant role in the brain-to-blood efflux transport of A beta(1-40) at the mouse BBB, but an unidentified transporter(s) appears to be involved.

Similar articles

• Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier.

  Ito S, Ohtsuki S, Terasaki T. Ito S, et al. Neurosci Res. 2006 Nov;56(3):246-52. doi: 10.1016/j.neures.2006.07.006. Epub 2006 Aug 22. Neurosci Res. 2006. PMID: 16926058

• LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

  Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic BV. Deane R, et al. Neuron. 2004 Aug 5;43(3):333-44. doi: 10.1016/j.neuron.2004.07.017. Neuron. 2004. PMID: 15294142

• The role of the low-density lipoprotein receptor-related protein 1 (LRP-1) in regulating blood-brain barrier integrity.

  Zhao Y, Li D, Zhao J, Song J, Zhao Y. Zhao Y, et al. Rev Neurosci. 2016 Aug 1;27(6):623-34. doi: 10.1515/revneuro-2015-0069. Rev Neurosci. 2016. PMID: 27206317 Review.

• [Macroglobulin signaling system].

  Zorin NA, Zorina VN. Zorin NA, et al. Biomed Khim. 2012 Jul-Aug;58(4):400-10. doi: 10.18097/pbmc20125804400. Biomed Khim. 2012. PMID: 23413684 Review. Russian.

Cited by

• Clearance systems in the brain-implications for Alzheimer disease.

  Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, Frangione B, Blennow K, Ménard J, Zetterberg H, Wisniewski T, de Leon MJ. Tarasoff-Conway JM, et al. Nat Rev Neurol. 2015 Aug;11(8):457-70. doi: 10.1038/nrneurol.2015.119. Epub 2015 Jul 21. Nat Rev Neurol. 2015. PMID: 26195256 Free PMC article. Review.

• A Historical Review of Brain Drug Delivery.

  Pardridge WM. Pardridge WM. Pharmaceutics. 2022 Jun 16;14(6):1283. doi: 10.3390/pharmaceutics14061283. Pharmaceutics. 2022. PMID: 35745855 Free PMC article. Review.

• Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.

  Zolezzi JM, Bastías-Candia S, Santos MJ, Inestrosa NC. Zolezzi JM, et al. Front Aging Neurosci. 2014 Jul 28;6:176. doi: 10.3389/fnagi.2014.00176. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25120477 Free PMC article. Review.

• 1α,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier.

  Ito S, Ohtsuki S, Nezu Y, Koitabashi Y, Murata S, Terasaki T. Ito S, et al. Fluids Barriers CNS. 2011 Jul 8;8:20. doi: 10.1186/2045-8118-8-20. Fluids Barriers CNS. 2011. PMID: 21740543 Free PMC article.

• Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood-cerebrospinal fluid barrier in human brain.

  Matsumoto K, Chiba Y, Fujihara R, Kubo H, Sakamoto H, Ueno M. Matsumoto K, et al. Histochem Cell Biol. 2015 Dec;144(6):597-611. doi: 10.1007/s00418-015-1366-7. Epub 2015 Oct 8. Histochem Cell Biol. 2015. PMID: 26449856

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal